Last 12 months
Inside the activity.
0 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
SaleCommon Stock | 1,000 | $21.78 | $21,775.00 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 7 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,607 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $21.21 to $22.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
Exercise / conversionCommon Stock | 3,750 | $8.04 | $30,150.00 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 6 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
SaleCommon Stock | 100 | $24.49 | $2,449.00 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 5 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
SaleCommon Stock | 400 | $23.25 | $9,300.00 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 4 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,957 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $23.16 to $23.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
SaleCommon Stock | 975 | $22.71 | $22,147.03 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 3 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,357 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $22.13 to $23.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
SaleCommon Stock | 400 | $21.52 | $8,606.00 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 2 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,332 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $20.92 to $21.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Bizily ScottChief Legal and HR Officer
|
Exercise / conversionCommon Stock | 1,875 | $6.49 | $12,168.75 |
DisclosureSEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 1 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F9 · balance_after: Reflects 2,857 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| September 23, 2022 Filed Sep 27, 2022 17:08 UTC |
Kasahara NoriyukiDirector
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001567619-22-017850 · doc1.xml · derivative · entry 1 Kasahara Noriyuki · CIK 0001943840 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2032-09-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on September 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on September 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| September 23, 2022 Filed Sep 27, 2022 21:05 UTC |
Kamal FariborzPresident & COO
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001567619-22-017847 · doc1.xml · derivative · entry 1 Kamal Fariborz · CIK 0001834020 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-09-22 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 23, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:38 UTC |
Bizily ScottChief Legal and HR Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001567619-22-017098 · doc1.xml · derivative · entry 1 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:42 UTC |
FISHMAN ROBERT SChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001567619-22-017102 · doc1.xml · derivative · entry 1 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:41 UTC |
Moretti August JChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001567619-22-017101 · doc1.xml · derivative · entry 2 Moretti August J · CIK 0001344412 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:40 UTC |
Kamal FariborzSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001567619-22-017099 · doc1.xml · derivative · entry 1 Kamal Fariborz · CIK 0001834020 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| June 18, 2022 Filed Jun 21, 2022 23:54 UTC |
Bizily ScottChief Legal and HR Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001567619-22-013209 · doc1.xml · derivative · entry 1 Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2032-06-17 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:00 UTC |
Chacko JacobDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011718 · doc1.xml · derivative · entry 1 Chacko Jacob · CIK 0001608936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:05 UTC |
MILLIGAN JOHN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 33,750 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011721 · doc1.xml · derivative · entry 1 MILLIGAN JOHN F · CIK 0001191589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 33,750 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:08 UTC |
Tomasello ShawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011723 · doc1.xml · derivative · entry 1 Tomasello Shawn · CIK 0001617239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:06 UTC |
THEUER CHARLESDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011722 · doc1.xml · derivative · entry 1 THEUER CHARLES · CIK 0001631338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:01 UTC |
GRAY SUSANNAHDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011719 · doc1.xml · derivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 23, 2022 Filed May 25, 2022 23:02 UTC |
Miller-Rich NancyDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001567619-22-011720 · doc1.xml · derivative · entry 1 Miller-Rich Nancy · CIK 0001735084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2032-05-22 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 17:42 UTC |
Zimmermann CarolyneChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001567619-22-002467 · doc1.xml · derivative · entry 1 Zimmermann Carolyne · CIK 0001860163 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 17:39 UTC |
FISHMAN ROBERT SChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001567619-22-002464 · doc1.xml · derivative · entry 1 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:43 UTC |
Moretti August JChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001567619-22-002468 · doc1.xml · derivative · entry 2 Moretti August J · CIK 0001344412 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:40 UTC |
Kirn DavidDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001567619-22-002466 · doc1.xml · derivative · entry 2 Kirn David · CIK 0001834021 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:39 UTC |
Kamal FariborzSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001567619-22-002465 · doc1.xml · derivative · entry 1 Kamal Fariborz · CIK 0001834020 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 21:42 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 1,900 | $31.00 | $58,892.78 |
DisclosureSEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 3 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901,215 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $30.76 to $31.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 21, 2021 Filed Oct 22, 2021 21:42 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 22,820 | $31.56 | $720,155.84 |
DisclosureSEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 2 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903,115 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $30.70 to $32.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 21:42 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 11,565 | $31.02 | $358,770.59 |
DisclosureSEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 1 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,935 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $30.27 to $32.07,inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 16:34 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 4,549 | $27.28 | $124,084.89 |
DisclosureSEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 5 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,500 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The transaction was executed in multiple trades in prices ranging from $27.08 to $27.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 16:34 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 7,836 | $26.69 | $209,164.78 |
DisclosureSEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 4 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942,049 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $26.07 to $27.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 16:34 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 700 | $30.06 | $21,044.17 |
DisclosureSEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 3 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 949,885 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $29.75 to $30.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 16:34 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 8,365 | $29.06 | $243,057.62 |
DisclosureSEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 2 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,585 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $28.71 to $29.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 16:34 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 7,806 | $27.99 | $218,511.80 |
DisclosureSEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 1 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 958,950 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $27.70 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 16:05 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 100 | $32.00 | $3,200.00 |
DisclosureSEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 5 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,756 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 16:05 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 13,812 | $30.52 | $421,492.52 |
DisclosureSEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 4 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,856 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 16:05 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 100 | $34.19 | $3,419.00 |
DisclosureSEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 3 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,668 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 16:05 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 6,157 | $33.51 | $206,330.31 |
DisclosureSEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 2 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,768 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 16:05 UTC |
SCHAFFER DAVIDDirector
|
SaleCommon Stock | 13,075 | $32.59 | $426,076.33 |
DisclosureSEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 1 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986,925 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Since the date of the reporting person's last ownership report, he transferred 1,000,000 shares of FDMT common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:28 UTC |
Zimmermann CarolyneChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $26.83 | $0.00 |
DisclosureSEC source: 0001567619-21-011946 · doc1.xml · derivative · entry 1 Zimmermann Carolyne · CIK 0001860163 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-06-06 F1 · derivative.exercise_date: The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:34 UTC |
SCHAFFER DAVIDDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010750 · doc1.xml · derivative · entry 1 SCHAFFER DAVID · CIK 0001692929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:33 UTC |
Chacko JacobDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010749 · doc1.xml · derivative · entry 1 Chacko Jacob · CIK 0001608936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:33 UTC |
MILLIGAN JOHN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,250 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010748 · doc1.xml · derivative · entry 2 MILLIGAN JOHN F · CIK 0001191589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2031-05-16 F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:33 UTC |
MILLIGAN JOHN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010748 · doc1.xml · derivative · entry 1 MILLIGAN JOHN F · CIK 0001191589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:31 UTC |
Tomasello ShawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010746 · doc1.xml · derivative · entry 1 Tomasello Shawn · CIK 0001617239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:36 UTC |
THEUER CHARLESDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010751 · doc1.xml · derivative · entry 1 THEUER CHARLES · CIK 0001631338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:32 UTC |
Miller-Rich NancyDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010747 · doc1.xml · derivative · entry 1 Miller-Rich Nancy · CIK 0001735084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:30 UTC |
GRAY SUSANNAHDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001567619-21-010745 · doc1.xml · derivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-05-16 F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program. F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan). Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:32 UTC |
Moretti August JChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001567619-21-008045 · doc1.xml · derivative · entry 2 Moretti August J · CIK 0001344412 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,060 Underlying: Common Stock · 1,000 shares Expires 2029-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal monthly installments until fully vested on January 7, 2023. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:32 UTC |
Moretti August JChief Financial Officer
|
Exercise / conversionCommon Stock | 1,000 | $9.41 | $9,410.00 |
DisclosureSEC source: 0001567619-21-008045 · doc1.xml · nonDerivative · entry 1 Moretti August J · CIK 0001344412 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:04 UTC |
Moretti August JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $41.66 | $0.00 |
DisclosureSEC source: 0001567619-21-005966 · doc1.xml · derivative · entry 1 Moretti August J · CIK 0001344412 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-03-07 F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 8, 2021 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.